You have no items in your shopping cart.
Brand Name : Omnipaque 350mg Infusion
Composition : Iohexol (350mg)
Manufactured By : Pfizer Ltd
Form : bottle
Packing : 50 ml in 1 bottle
Save an Extra $25 on Every Buy!
Valid for all users
Omnipaque 350mg Infusion Description:
Iohexol belongs to a class of drugs known as radiographic contrast agents. It enhances imaging due to its high Iodine content attenuating the beam of X-rays during examination.
Omnipaque 350mg Infusion is used in diagnosis of disease of spinal cord.
Nausea, Vomiting, Diarrhoea.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How does Iohexol work?
Iohexol contains iodine and works by enhancing contrasts to body parts and fluids. Iohexol improves the images obtained during a CT scan for easily diagnose your condition
Is Iohexol radioactive?
No, it is not radioactive
Is Iohexol water soluble?
Yes. Iohexol is a water soluble iodinated contrast medium.
Buy Omnipaque 350mg Infusion Online From India At Best Price
If you are looking to buy Iohexol (350mg) (50 ml in 1 bottle) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.
Order Online to Get Omnipaque 350mg Infusion in -
South East Asia - China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.
United Arab Emirates (UAE) - Iran, Saudi Arabia, Jordan.
North America - Venezuela, USA (United States of America), Suriname.
South America - Argentina, Chile, Colombia, Peru, Venezuela.
Europe - Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.
Russia CIS - Moldova, Uzbekistan, Kyrgyzstan.
African Countries - Nigeria, Kenya, Morocco, Libya, Zimbabwe.
Other Countries - Malaysia, Egypt, Australia, Italy and New Zealand.